| Name | FASN-IN-2 |
|---|---|
| Synonyms |
TVB-2640
EOS-61292 ASC-40 TVB2640 Denifanstat 4-(1-(4-Cyclobutyl-2-methyl-5-(3-methyl-1H-1,2,4-triazol-5-yl)benzoyl)piperidin-4-yl)benzonitrile 4-(1-(4-cyclobutyl-2-methyl-5-(5-methyl-4H-1,2,4-triazol-3-yl)benzoyl)piperidin-4-yl)benzonitrile Benzonitrile, 4-[1-[4-cyclobutyl-2-methyl-5-(3-methyl-1H-1,2,4-triazol-5-yl)benzoyl]-4-piperidinyl] ASC 40 SS-CoV2,ASC40,Denifanstat,TVB 2640,Inhibitor,spike,inhibit,ASC 40,Fatty Acid Synthase (FASN),protein,COVID-19,ASC-40 TVB-2640(FASN-IN-2) ASC40 Denifanstat (TVB-2640) FASN inhibitor 2 Denifanstat, 10 mM in DMSO |
| Description | FASN-IN-2 is a Fatty Acid Synthase (FASN) inhibitor extracted from patent WO2012122391A1, compound 152, has an IC50 of 0.052 μM and an EC50 of 0.072 μM[1]. |
|---|---|
| Related Catalog | |
| Target |
IC50: 0.052 μM (FASN)[1] |
| References |
[1]. Johan D., et al. Heterocyclic modulators of lipid synthesis. WO2012122391A1. |
| Molecular Formula | C27H29N5O |
|---|---|
| Molecular Weight | 439.55 |